Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03846921

Enrollment

100

Registered

2019-02-20

Start date

2019-03-04

Completion date

2020-03-31

Last updated

2019-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Infections, Viral Infection

Brief summary

This study aims to investigate the use of alpha-defensin as a diagnostic means to distinguish between acute bacterial and viral infections.

Interventions

DIAGNOSTIC_TESTLaboratory blood test

Laboratory blood test will be analyzed to determine whether there is a rise in alpha-defensin

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 18 Years

Healthy volunteers

Inclusion criteria

* Children with either bacterial or viral infections

Exclusion criteria

* All others

Design outcomes

Primary

Measure	Time frame	Description
Rise in alpha-defensin	One year	Laboratory blood tests will be analyzed to determine whether there is a rise in alpha-defensin levels in bacterial infections as compared to viral infections.

Countries

Israel

Contacts

Primary ContactEias Kassem, MD

eiask@hy.health.gov.il972-50-6246882

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026